Omada Health, Inc. (OMDA) Stock Forecast
OMDA analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.25 / 5 from 12 analysts
- Price target
- $28.42 average of analyst targets
- Upside to target
- +61.2% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $0.01
- 52-week range
- $10.94 – $26.78
OMDA analyst ratings
12 analystsNumber of analysts at each rating.
OMDA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
OMDA earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.10 | $0.08 | $0.12 | $0.03 | +229.2% | 5 |
| Current fiscal year (2026) | $0.44 | $0.38 | $0.48 | $0.15 | +181.5% | 5 |
| Next fiscal year (2027) | $0.56 | $0.39 | $0.66 | $0.44 | +27.6% | 5 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
OMDA revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $85.6M | $84.5M | $86.4M | +25.9% | 10 |
| Current fiscal year (2026) | $338.7M | $336.9M | $344.4M | +30.2% | 11 |
| Next fiscal year (2027) | $407.8M | $395.0M | $416.3M | +20.4% | 11 |
OMDA EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
OMDA revenue: reported and forecast
OMDA EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.09 | $0.08 | $0.10 | $0.10 | $0.10 | +9.9% | 4 up · 0 down |
| Current fiscal year (2026) | $0.33 | $0.31 | $0.44 | $0.44 | $0.44 | +33.5% | 5 up · 0 down |
| Next fiscal year (2027) | $0.48 | $0.47 | $0.56 | $0.56 | $0.56 | +16.7% | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
OMDA earnings surprises
Reported EPS vs the consensus estimate for the last 6 quarters; OMDA beat in 4 of 6.
What analysts expect from OMDA
12 analysts cover Omada Health; their consensus rating is buy (4.25 on a 1–5 scale, where 5 is a strong buy). The average price target is $28.42, 61.2% above the latest close of $17.63. Analysts expect earnings of $0.44 per share for 2026, +181.5% from a year earlier. For 2027 the average estimate is $0.56 per share on revenue of $407.8 million. Omada Health beat the EPS estimate in 4 of the last 6 quarters.
Related: OMDA income statement, OMDA key metrics, OMDA chart. See the OMDA stock overview for the latest quote and news.
OMDA forecast FAQ
What is Omada Health's price target?
The average analyst price target for Omada Health is $28.42, 61.2% above the latest close of $17.63.
Is Omada Health a buy, hold or sell?
Of 12 analysts covering Omada Health, 5 rate it a strong buy, 5 a buy, 2 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Omada Health's EPS forecast?
Analysts forecast $0.44 per share for 2026 (range $0.38 to $0.48); for 2027 the estimate is $0.56.
What is Omada Health's revenue forecast?
The average revenue estimate for 2026 is $338.7 million, growth of 30.2%; for 2027 it is $407.8 million.
When does Omada Health report earnings?
Omada Health is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $0.01.
Does Omada Health usually beat earnings estimates?
Omada Health reported EPS at or above the analyst estimate in 4 of the last 6 quarters.